Institution · Novartis (Switzerland)
Most cited papers from Novartis (Switzerland)
What are the most cited papers from Novartis (Switzerland)?
The most cited paper from Novartis (Switzerland) is "Development and testing of a general amber force field" (Junmei Wang, Romain M. Wolf, James W. Caldwell et al., 2004), with 20,214 citations. Next come "Metascape provides a biologist-oriented resource for the analysis of systems-level datasets" (16,072) and "Simultaneous Inference in General Parametric Models" (14,308).
Showing 50 of 60 papers. Every paper with more than 2,090 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Development and testing of a general amber force field Junmei Wang, Romain M. Wolf, James W. Caldwell et al. · Journal of Computational Chemistry | 13 Apr 2004 | 20,214 |
| 2 | Metascape provides a biologist-oriented resource for the analysis of systems-level datasets Yingyao Zhou, Bin Zhou, Lars Pache et al. · Nature Communications | 3 Apr 2019 | 16,072 |
| 3 | Simultaneous Inference in General Parametric Models Torsten Hothorn, Frank Bretz, Peter H. Westfall · Biometrical Journal | 15 May 2008 | 14,308 |
| 4 | A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules Wendy D. Cornell, Piotr Cieplak, Christopher I. Bayly et al. · Journal of the American Chemical Society | May 1995 | 13,239 |
| 5 | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease Paul M. Ridker et al. · New England Journal of Medicine | 27 Aug 2017 | 9,517 |
| 6 | The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity Jordi Barretina et al. · Nature | 27 Mar 2012 | 8,623 |
| 7 | Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia Shannon L. Maude et al. · New England Journal of Medicine | 31 Jan 2018 | 5,818 |
| 8 | Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia Brian J. Druker, Moshe Talpaz, Debra J. Resta et al. · New England Journal of Medicine | 5 Apr 2001 | 5,296 |
| 9 | Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing Raymond R. Tice, Eva Agurell, Diana Anderson et al. · Environmental and Molecular Mutagenesis | 6 Jun 2000 | 4,883 |
| 10 | Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors George D. Demetri et al. · New England Journal of Medicine | 15 Aug 2002 | 4,425 |
| 11 | FinnGen provides genetic insights from a well-phenotyped isolated population Mitja Kurki et al. · Nature | 18 Jan 2023 | 4,362 |
| 12 | Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma Stephen J. Schuster et al. · New England Journal of Medicine | Dec 2018 | 4,157 |
| 13 | Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Robin P. Sherrington et al. · Nature | Jun 1995 | 4,080 |
| 14 | Orchestrating high-throughput genomic analysis with Bioconductor Wolfgang K. Huber et al. · Nature Methods | 29 Jan 2015 | 4,076 |
| 15 | Core outcome measures for chronic pain clinical trials: IMMPACT recommendations Robert H. Dworkin et al. · Pain | 6 Nov 2004 | 3,789 |
| 16 | Next-generation characterization of the Cancer Cell Line Encyclopedia Mahmoud Ghandi et al. · Nature | May 2019 | 3,789 |
| 17 | Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics Fariborz Mohamadi, Nigel G. J. Richards, Wayne C. Guida et al. · Journal of Computational Chemistry | May 1990 | 3,774 |
| 18 | Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells Brian J. Druker, Shu Tamura, Elisabeth Buchdunger et al. · Nature Medicine | May 1996 | 3,681 |
| 19 | A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis Hervé Groux, Anne O’Garra, Mike Bigler et al. · Nature | Oct 1997 | 3,601 |
| 20 | Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Stephen G. O’Brien et al. · New England Journal of Medicine | 12 Mar 2003 | 3,593 |
| 21 | A gene atlas of the mouse and human protein-encoding transcriptomes Andrew I. Su, Tim Wiltshire, Serge Batalov et al. · Proceedings of the National Academy of Sciences | 9 Apr 2004 | 3,558 |
| 22 | Core outcome domains for chronic pain clinical trials: IMMPACT recommendations Dennis C. Turk et al. · Pain | 22 Sep 2003 | 3,518 |
| 23 | Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia Brian J. Druker et al. · New England Journal of Medicine | 6 Dec 2006 | 3,508 |
| 24 | Piezo1 and Piezo2 Are Essential Components of Distinct Mechanically Activated Cation Channels Bertrand Coste, Jayanti Mathur, Manuela Schmidt et al. · Science | 2 Sep 2010 | 3,398 |
| 25 | Membrane transporters in drug development Kathleen M. Giacomini et al. · Nature Reviews Drug Discovery | Mar 2010 | 3,373 |
| 26 | ERBB receptors and cancer: the complexity of targeted inhibitors Nancy E. Hynes, Heidi A. Lane · Nature reviews. Cancer | 29 Apr 2005 | 3,349 |
| 27 | Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia Roger A. Fielding et al. · Journal of the American Medical Directors Association | 5 Mar 2011 | 3,319 |
| 28 | Miniaturized total chemical analysis systems: A novel concept for chemical sensing A. Manz, N. Graber, H. Michael. Widmer · Sensors and Actuators B Chemical | 1990 | 3,107 |
| 29 | Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties Peter F. Ertl, Bernhard Rohde, Paul M. Selzer · Journal of Medicinal Chemistry | 19 Sep 2000 | 3,103 |
| 30 | Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial Robert John Motzer, Bernard J. Escudier, Stéphane Marie. Oudard et al. · The Lancet | 23 Jul 2008 | 3,036 |
| 31 | Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis Dennis M. Black et al. · New England Journal of Medicine | 3 May 2007 | 2,988 |
| 32 | Everolimus for Advanced Pancreatic Neuroendocrine Tumors James C. Yao, Manisha H. Shah, Tetsuhide Ito et al. · New England Journal of Medicine | 9 Feb 2011 | 2,877 |
| 33 | Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis Aurélien Trompette, Eva S. Gollwitzer, Koshika Yadava et al. · Nature Medicine | 5 Jan 2014 | 2,877 |
| 34 | Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer José Baselga et al. · New England Journal of Medicine | 7 Dec 2011 | 2,868 |
| 35 | Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer Oliver A. Sartor, Johann Sebastian De Bono, Kim N. Chi et al. · New England Journal of Medicine | 23 Jun 2021 | 2,834 |
| 36 | Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury David R. Janero · Free Radical Biology and Medicine | 1990 | 2,736 |
| 37 | Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites William R. Wikoff, Andrew Anfora, Jun Liu et al. · Proceedings of the National Academy of Sciences | 21 Feb 2009 | 2,701 |
| 38 | Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup Clifford R. Jack, Jeffrey Scott Andrews, Thomas G. Beach et al. · Alzheimer s & Dementia | 27 Jun 2024 | 2,670 |
| 39 | Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer Fabrice André, Eva M. Ciruelos, Gábor Rubovszky et al. · New England Journal of Medicine | 15 May 2019 | 2,660 |
| 40 | A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor et al. · New England Journal of Medicine | 20 Jan 2010 | 2,658 |
| 41 | mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt Kathryn E O'Reilly, F. Rojo, Qing‐Bai She et al. · Cancer Research | Feb 2006 | 2,599 |
| 42 | Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 Mehrdad Matloubian, Charles G. Lo, Guy Cinamon et al. · Nature | 2004 | 2,592 |
| 43 | Shock and Tissue Injury Induced by Recombinant Human Cachectin Kevin J. Tracey, Bruce Beutler, Stephen F. Lowry et al. · Science | 24 Oct 1986 | 2,572 |
| 44 | Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial Stevo Julius, Sverre Erik Kjeldsen, Michael A. Weber et al. · The Lancet | Jun 2004 | 2,564 |
| 45 | CSF-1R inhibition alters macrophage polarization and blocks glioma progression Stephanie M. Pyonteck, Leila Akkari, Alberto J. Schuhmacher et al. · Nature Medicine | 22 Sep 2013 | 2,544 |
| 46 | More than 50 long-term effects of COVID-19: a systematic review and meta-analysis Sandra López‐León, Talía Wegman-Ostrosky, Carol Perelman et al. · Scientific Reports | 9 Aug 2021 | 2,523 |
| 47 | ANKTM1, a TRP-like Channel Expressed in Nociceptive Neurons, Is Activated by Cold Temperatures Gina M. Story, Andrea M. Peier, Alison J. Reeve et al. · Cell | Mar 2003 | 2,510 |
| 48 | Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both Marc Alan Pfeffer, John J.V. McMurray, Eric J. Velazquez et al. · New England Journal of Medicine | 12 Nov 2003 | 2,492 |
| 49 | A TRP Channel that Senses Cold Stimuli and Menthol Andrea M. Peier, Aziz Moqrich, Anne C. Hergarden et al. · Cell | Mar 2002 | 2,377 |
| 50 | Metabolic Syndrome in Childhood: Association With Birth Weight, Maternal Obesity, and Gestational Diabetes Mellitus Charlotte M. Boney, Anila Verma, Richard J. Tucker et al. · PEDIATRICS | Mar 2005 | 2,338 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.